Baghdadi Y, Bourrée A, Robert A, Rey G, Gallay A, Zweigenbaum P, et al. A New Approach to Compare the Performance of Two Classification Methods of Causes of Death for Timely Surveillance in France. Stud Health Technol Inform. 2019 Aug 21;264:925–9.
Latouche A, Andersen PK, Rey G, Moreno-Betancur M. A Note on the Measurement of Socioeconomic Inequalities in Life Years Lost by Cause of Death. Epidemiology. 2019 Jun 11;
Baghdadi Y, Bourrée A, Robert A, Rey G, Gallay A, Zweigenbaum P, et al. Automatic classification of free-text medical causes from death certificates for reactive mortality surveillance in France. Int J Med Inform. 2019;131:103915.
Droitcourt C, Nowak E, Rault C, Happe A, Le Nautout B, Kerbrat S, et al. Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study. Int J Epidemiol. 2019 01;48(5):1623–35.
Barro SG, Rey G, Staccin P. Study of the Usability of an Automated Coding Software for Causes of Death in an African Context. Stud Health Technol Inform. 2019 Aug 21;264:1978–9.
Jougla E, Papoz L, Balkau B, Maguin P, Hatton F. Death certificate coding practices related to diabetes in European countries--the “EURODIAB Subarea C” Study. Int J Epidemiol [Internet]. 1992 Apr [cited 2012 Jun 27];21(2):343–5Available from: http://www.ncbi.nlm.nih.gov/pubmed/1428491
Jougla E, Hatton F, Le Toullec A, Michel E. [Trends in mortality characteristics in Aids in France 1983-1990]. Rev Epidemiol Sante Publique [Internet]. 1992 [cited 2012 Jun 27];40(3):164–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1439058
Mackenbach JP, Bouvier-Colle MH, Jougla E. “Avoidable” mortality and health services: a review of aggregate data studies. J Epidemiol Community Health [Internet]. 1990 Jun [cited 2012 Jun 27];44(2):106–1Available from: http://www.ncbi.nlm.nih.gov/pubmed/2196328
Benhamou D, Lienhart A, Auroy Y, Péquignot F, Jougla E. Accidents by ABO incompatibility and other main complications related to blood transfusion in surgical patients: data from the French national survey on anaesthesia-related deaths. Transfus Clin Biol. 2005 Nov;12(5):389–90.
Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005 Feb;34(1):121–30.
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005 Jun;42(6):799–805.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37(6–7):482–7.
Nelson DE, Jarman DW, Rehm J, Greenfield TK, Rey G, Kerr WC, et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health. 2013 Apr;103(4):641–8.
Hoffmann R, Plug I, Khoshaba B, McKee M, Mackenbach JP, AMIEHS working group. Amenable mortality revisited: the AMIEHS study. Gac Sanit. 2013 Jun;27(3):199–206.
Menvielle G, Rey G, Jougla E, Luce D. Diverging trends in educational inequalities in cancer mortality between men and women in the 2000s in France. BMC Public Health. 2013 Sep 10;13(1):823.
Hoffmann R, Plug I, McKee M, Khoshaba B, Westerling R, Looman C, et al. Innovations in health care and mortality trends from five cancers in seven European countries between 1970 and 2005. Int J Public Health. 2013 Aug 29;
Hoffmann R, Plug I, McKee M, Khoshaba B, Westerling R, Looman C, et al. Innovations in medical care and mortality trends from four circulatory diseases between 1970 and 2005. Eur J Public Health. 2013 Oct;23(5):852–7.
Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, Celermajer DS, et al. Mortality of French participants in the Tour de France (1947-2012). Eur Heart J. 2013 Oct;34(40):3145–50.
Rafnsson SB, Bhopal RS, Agyemang C, Fagot-Campagna A, Harding S, Hammar N, et al. Sizable variations in circulatory disease mortality by region and country of birth in six European countries. Eur J Public Health. 2013 Aug;23(4):594–605.
Ghosn W, Kassie D, Jougla E, Rican S, Rey G. Spatial interactions between urban areas and cause-specific mortality differentials in France. Health Place. 2013 Nov;24:234–41.
Ghosn W, Kassié D, Jougla E, Salem G, Rey G, Rican S. Trends in geographic mortality inequalities and their association with population changes in France, 1975-2006. Eur J Public Health. 2013 Oct;23(5):834–40.
Mackenbach JP, Hoffmann R, Khoshaba B, Plug I, Rey G, Westerling R, et al. Using “amenable mortality” as indicator of healthcare effectiveness in international comparisons: results of a validation study. J Epidemiol Community Health. 2013 Feb;67(2):139–46.
Lewden C, Bonnet F, Bevilacqua S, Heripret L, May T, Morlat P, et al. [Causes of death in HIV-infected French drug users, 1995-2000]. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S4-10.
Clergue F, Auroy Y, Pequignot F, Jougla E, Lienhart A, Laxenaire MC. Evolution of the anaesthetic workload--the French experience. Best Pract Res Clin Anaesthesiol. 2002 Sep;16(3):459–73.